Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein, tau - PubMed

Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein, tau

N J Pollock et al. Lancet. 1986.

Similar articles

• Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles.

  Bancher C, Lassmann H, Budka H, Grundke-Iqbal I, Iqbal K, Wiche G, Seitelberger F, Wisniewski HM. Bancher C, et al. Acta Neuropathol. 1987;74(1):39-46. doi: 10.1007/BF00688336. Acta Neuropathol. 1987. PMID: 2444063

• Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.

  Joachim CL, Morris JH, Kosik KS, Selkoe DJ. Joachim CL, et al. Ann Neurol. 1987 Oct;22(4):514-20. doi: 10.1002/ana.410220411. Ann Neurol. 1987. PMID: 2963585

• Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease.

  Goedert M, Spillantini MG. Goedert M, et al. Biochim Biophys Acta. 2000 Jul 26;1502(1):110-21. doi: 10.1016/s0925-4439(00)00037-5. Biochim Biophys Acta. 2000. PMID: 10899436 Review.

• Mutations causing neurodegenerative tauopathies.

  Goedert M, Jakes R. Goedert M, et al. Biochim Biophys Acta. 2005 Jan 3;1739(2-3):240-50. doi: 10.1016/j.bbadis.2004.08.007. Biochim Biophys Acta. 2005. PMID: 15615642 Review.

Cited by

• Liquid-liquid phase separation of tau: From molecular biophysics to physiology and disease.

  Rai SK, Savastano A, Singh P, Mukhopadhyay S, Zweckstetter M. Rai SK, et al. Protein Sci. 2021 Jul;30(7):1294-1314. doi: 10.1002/pro.4093. Epub 2021 May 14. Protein Sci. 2021. PMID: 33930220 Free PMC article. Review.

• Occurrence of 15-nm-wide straight tubules in neocortical neurons in progressive supranuclear palsy.

  Takahashi H, Oyanagi K, Takeda S, Hinokuma K, Ikuta F. Takahashi H, et al. Acta Neuropathol. 1989;79(3):233-9. doi: 10.1007/BF00294656. Acta Neuropathol. 1989. PMID: 2609933

• Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport.

  Kanaan NM, Morfini G, Pigino G, LaPointe NE, Andreadis A, Song Y, Leitman E, Binder LI, Brady ST. Kanaan NM, et al. Neurobiol Aging. 2012 Apr;33(4):826.e15-30. doi: 10.1016/j.neurobiolaging.2011.06.006. Epub 2011 Jul 27. Neurobiol Aging. 2012. PMID: 21794954 Free PMC article.

• Targets for AD treatment: conflicting messages from γ-secretase inhibitors.

  Sambamurti K, Greig NH, Utsuki T, Barnwell EL, Sharma E, Mazell C, Bhat NR, Kindy MS, Lahiri DK, Pappolla MA. Sambamurti K, et al. J Neurochem. 2011 May;117(3):359-74. doi: 10.1111/j.1471-4159.2011.07213.x. Epub 2011 Mar 15. J Neurochem. 2011. PMID: 21320126 Free PMC article.

• Exposure of the Amino Terminus of Tau Is a Pathological Event in Multiple Tauopathies.

  Combs B, Kanaan NM. Combs B, et al. Am J Pathol. 2017 Jun;187(6):1222-1229. doi: 10.1016/j.ajpath.2017.01.019. Epub 2017 Apr 14. Am J Pathol. 2017. PMID: 28413156 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information